SCHEMBL5845314

SCHEMBL5845314

Cc1cc(Cl)ccc1-c1ccc(N)c(O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.52
ALOX15 P16050 3/20 0.52
HSD17B10 Q99714 2/20 0.52
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44
MAPK1 P28482 1/20 0.44
ESR2 Q92731 5/20 0.42
ESR1 P03372 2/20 0.42
TLR8 Q9NR97 1/20 0.40
TSHR P16473 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALOX5 P09917 2/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
ABL1 P00519 1/20 0.38
MAP4K4 O95819 1/20 0.38
NOTUM Q6P988 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5845543 0.87 CYP3A4 (0.52) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL5845267 0.83 HSD17B10 (0.55) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL5845352 0.83 ALOX15 (0.55) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL23137331 0.82 ALOX15 (0.64) CYP3A4ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL5845306 0.80 HSD17B10 (0.52) CYP3A4ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL18393099 0.80 CYP3A4 (0.44) CYP3A4ALOX15ALDH1A1SMN1; SMN2TSHR
SCHEMBL5845307 0.80 ALOX15 (0.52) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL5843853 0.79 CYP3A4 (0.55) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2
SCHEMBL26976334 0.79 ALOX15 (0.59) CYP3A4ALOX15HSD17B10ALDH1A1HPGD
SCHEMBL5843930 0.78 ALOX15 (0.53) CYP3A4ALOX15HSD17B10ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US claimed
EP-1562539-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES Wella Aktiengesellschaft (DE) 2005-08-17 EP claimed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US claimed
WO-2004041226-A1 AGENTS FOR DYEING KERATIN FIBERS, CONTAINING 4-AMINO-BIPHENYL-3-OL-DERIVATIVES WELLA AKTIENGESELLSCHAFT (DE) 2004-05-21 WO claimed
US-7122061-B2 Agents for dyeing keratin fibers, containing 4-aminobiphenyl-3-ol-derivatives WELLA AG (DE) 2006-10-17 US disclosed
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives WELLA AKTIENGESELLSCHAFT (DE) 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050155160-A1 Agents for dyeing keratin fibers, containing 4-amino-biphenyl-3-ol-derivatives KRT18, CBR3, CCNB3 CYP3A4 835/4885ALOX15 3006/4885HSD17B10 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.